December 19, 2019 — The U.S. Food and Drug Administration (FDA) has granted breakthrough status for a novel ECG-based algorithm that could provide an easily accessible screening test for heart failure. Developed by Eko, a digital health company applying artificial intelligence (AI) in heart disease, the algorithm analyzes 15 seconds of ECG data collected from the Eko Duo digital stethoscope. The…
We are rallying to support our friend and community leader Th… Thomas Redwood needs your support for Support Russell’s (Thomas) Heart Transplant Journey
Join us for the first annual F*CK ALS Gala, a glamourous night of giving and grooving dedicated to supporting young women diagnosed with ALS (Amyotrophic…
FDA is in a quandary about compounding of the new obesity drugs, semaglutide and tirzepatide. The nominee to lead FDA has an interest.
Success by Sesame offers affordable, comprehensive online weight loss with top-rated doctors. Includes weight loss medication prescription if eligible, labs, unlimited messaging & more.
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04848857.
This expert consensus statement summarizes the available data regarding the prognostic value of CAC in the asymptomatic population and its ability to refine individual risk…
URL: https://www.clinicaltrials.gov; Unique identifier: NCT04848857.
Hopin Lee, Jeffrey K Aronson and David Nunan blog about how to tell when an association does and does not mean causation in health research…
1,191 likes, 9 comments – pasadenapaws on July 15, 2024: “We heard about Stewie through lifesaver @flores78__ and when @wishbone_rescue offered to take him in…
